TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.
Tabori
Uri
U
The Hospital for Sick Children, Division of Hematology/Oncology, 555 University Ave, Toronto, Ontario, M5G 1X8, Canada.
Shlien
Adam
A
Baskin
Berivan
B
Levitt
Sarah
S
Ray
Peter
P
Alon
Noa
N
Hawkins
Cynthia
C
Bouffet
Eric
E
Pienkowska
Malgorzata
M
Lafay-Cousin
Lucie
L
Gozali
Alexa
A
Zhukova
Nataliya
N
Shane
Lisa
L
Gonzalez
Ignacio
I
Finlay
Jonathan
J
Malkin
David
D
D002277:Carcinoma / Q000737:chemistry / Q000235:genetics* / Q000401:mortality / Q000628:therapy; D016009:Chi-Square Distribution; D002648:Child; D002675:Child, Preschool; D016545:Choroid Plexus Neoplasms / Q000737:chemistry / Q000235:genetics* / Q000401:mortality / Q000628:therapy; D019992:Databases as Topic; D018572:Disease-Free Survival; D015972:Gene Expression Regulation, Neoplastic; D020022:Genetic Predisposition to Disease; D018095:Germ-Line Mutation; D006801:Humans; D007150:Immunohistochemistry; D053208:Kaplan-Meier Estimate; D020411:Oligonucleotide Array Sequence Analysis; D009864:Ontario / Q000453:epidemiology; D020288:Papilloma, Choroid Plexus / Q000737:chemistry / Q000235:genetics* / Q000401:mortality / Q000628:therapy; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide; D013997:Time Factors; D016896:Treatment Outcome; D016159:Tumor Suppressor Protein p53 / Q000032:analysis / Q000235:genetics*; D014481:United States / Q000453:epidemiology
C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53